NCT05747625 2025-12-19(89Zr Panitumumab) With PET/CT for Diagnosing Metastases in Patients With Head and Neck Squamous Cell CarcinomaVanderbilt-Ingram Cancer CenterPhase 1 Recruiting60 enrolled